David A. Siegel Dynavax Technologies Corp Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 16,018 shares of DVAX stock, worth $179,882. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,018
Previous 160,918
90.05%
Holding current value
$179,882
Previous $2.25 Million
91.2%
% of portfolio
0.0%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding DVAX
# of Institutions
269Shares Held
132MCall Options Held
326KPut Options Held
758K-
Black Rock Inc. New York, NY23.2MShares$260 Million0.01% of portfolio
-
State Street Corp Boston, MA10.6MShares$119 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.4MShares$106 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT9.14MShares$103 Million3.75% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA7.99MShares$89.7 Million0.23% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.42B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...